7/21/2022 7:56:38 AM
Incannex Gets Ethics Approval To Commence Phase 1 Trial Of Multi-Use Anti-Inflammatory Drug IHL-675A
6/3/2022 7:58:31 AM
Incannex Announces Positive Results From Phase 2 Trial Of IHL-42X For Treatment Of Obstructive Sleep Apnoea
5/17/2022 7:58:03 AM
Incannex Announces Positive Pre-IND Meeting With FDA For IHL-42X For Obstructive Sleep Apnoea
3/24/2022 7:58:52 AM
Incannex Agrees To Acquire APIRx Pharmaceuticals USA, LLC